Literature DB >> 20563846

The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey.

Aza Mohammed1, Ammar Hameed, Iqbal Shergill, Jayanta Barua.   

Abstract

OBJECTIVES: To determine the current trends in the follow-up of patients with muscle-invasive bladder cancer following radiotherapy, among consultants in the United Kingdom and the republic of Ireland in terms of cystoscopic survey and imaging of the upper tracts.
METHODS: A national postal survey was carried out in 2006 including 602 urologists registered with the British Association of Urological Surgeons (BAUS).
RESULTS: About 40% of the consultants participated in the survey. Seventy-seven per cent performed cystoscopy 3 months post-radiotherapy and 78% used rigid cystoscopy. The majority (91%) did not take routine random biopsies at the time of the first cystoscopy if it looked normal. Seventy-eight per cent of the participants requested upper-tract imaging in the presence of cystoscopic abnormalities, and long-term follow-up was recommended by 75%.
CONCLUSIONS: There is a wide-range of practice regarding the first check cystoscopy following radiotherapy for muscle-invasive bladder cancer and it could prove the foundation for more randomised trials to determine the evidence-based practice.

Entities:  

Mesh:

Year:  2010        PMID: 20563846     DOI: 10.1007/s11255-010-9789-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Why the flexible cystoscope has not yet been widely introduced?: A questionnaire to Japanese urologists.

Authors:  R Yoshimura; S Wada; T Kishimoto
Journal:  Int J Urol       Date:  1999-11       Impact factor: 3.369

2.  The flexible cystoscope.

Authors:  M Pavone-Macaluso; M Lamartina; C Pavone; M Vella
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

3.  [Follow up of urinary bladder cancer--a task for the urology nurse?].

Authors:  Matilda Fagerberg; Per-Olof Nostell
Journal:  Lakartidningen       Date:  2005 Jul 25-Aug 7

4.  Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group.

Authors:  S Hellsten; E Rintala; R Wahlqvist; P U Malmström
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

5.  The changing pattern of mortality and morbidity from radical cystectomy.

Authors:  D J Rosario; M Becker; J B Anderson
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

6.  Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Donald S Kaufman; Michael P Hagan; Niall M Heney; Howard M Sandler
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

7.  Bladder cancer incidence and mortality rates compared to ecologic factors among states in America.

Authors:  Janet L Colli; Peter N Kolettis
Journal:  Int Urol Nephrol       Date:  2009-10-07       Impact factor: 2.370

8.  Biopsy of the red patch at cystoscopy: is it worthwhile?

Authors:  M J Swinn; M M Walker; L J Harbin; J M Adshead; R O'N Witherow; J A Vale; A Patel
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

9.  Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.

Authors:  Christian Weiss; Michael Wittlinger; Dirk G Engehausen; Frens S Krause; Oliver J Ott; Jürgen Dunst; Rolf Sauer; Claus Rödel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-01       Impact factor: 7.038

10.  The ileal neobladder: complications and functional results in 363 patients after 11 years of followup.

Authors:  R E Hautmann; R de Petriconi; H W Gottfried; K Kleinschmidt; R Mattes; T Paiss
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  1 in total

Review 1.  [Follow-up of bladder cancer : The right examinations at the right time].

Authors:  P Olbert; P J Goebell; A Hegele
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.